- The SHOCKING Truth About Ozempic Side Effects (And How To . . . - YouTube
Calley Means, co-author of Good Energy, breaks down the "macro" problem: how Big Pharma and a broken food system have created a metabolic health crisis and are now positioning Ozempic as a
- Podcast Video: GLP 1, Mounjaro Ozempic: How These . . . - Casey Means MD
Medications, such as Ozempic, Mounjaro, Wegovy, and more, have become increasingly popular for weight loss These drugs are glucagon-like peptide 1 (GLP-1) receptor agonists, and they mimic a hormone that, among other things, tells the brain a person is full so they eat less But are they safe, and do they help improve metabolic health?
- What Eli Lilly Thinks of Trumps Plan + Calley Means Promises Cheaper . . .
Which brings us to the second plot twist Calley Means accidentally makes the case for GLP-1s In a quote shared by RFK Jr adviser Calley Means, yes, that Calley Means, we got a glimpse of how even GLP-1 critics are starting to see the writing on the wall Speaking about the Trump Executive Order on the topic of GLP-1 drugs, Calley said this:
- Episode: The Shocking Truth About Ozempic The Effects It Has On The . . .
The episode explores the multifaceted role of GLP-1 agonists like Ozempic in treating obesity and metabolic health issues Mark Hyman, Calley Means, and Dr Tyna Moore discuss the benefits, risks, and ethical considerations surrounding these drugs
- #226 – How do weight-loss medications affect metabolic . . . - Levels
35:46 — How can patients use GLP-1 RAs as a jumpstart? Dr Means and Dr Lustig propose that GLP-1 RAs could be a jumpstart for people to gain momentum in improving their metabolic health In that case, potentially people wouldn’t need to be on the medications long term for sustained weight loss
- Ozempic: A Weight Loss Miracle or Metabolic Menace?
This deep-dive into Ozempic with Dr Mark Hyman, Dr Tyna Moore, and Calley Means takes a look at both sides of a controversial treatment
- The Ozempic Debate: Should We Take GLP-1s for Weight Loss?
The Critic: Calley Means criticizes Ozempic and other GLP-1 agonists because he’s looking at things from a wider angle He thinks that, as a society, we need to focus on what has caused our obesity epidemic in the first place, namely: ultra-processed foods, big food corporations, modern farming practices, etc
- The Right and Wrong Way to Use Ozempic and Other GLP-1 Agonists
Episode 427 The Right and Wrong Way to Use Ozempic and Other GLP-1 Agonists With JJ Virgin Calley Means Dr Gabrielle Lyon Dr Casey Means Dr Robert Lustig If playback doesn't begin shortly, try restarting your device
|